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Abstract
Counterfactual prediction is a fundamental task
in decision-making. G-computation is a method
for estimating expected counterfactual outcomes
under dynamic time-varying treatment strate-
gies. Existing G-computation implementations
have mostly employed classical regression mod-
els with limited capacity to capture complex tem-
poral and nonlinear dependence structures. This
paper introduces G-Net, a novel sequential deep
learning framework for G-computation that can
handle complex time series data while impos-
ing minimal modeling assumptions and provide
estimates of individual or population-level time-
varying treatment effects. We evaluate alterna-
tive G-Net implementations using realistically
complex temporal simulated data obtained from
CVSim, a mechanistic model of the cardiovascu-
lar system.
1 Introduction
Counterfactual prediction is a fundamental task in decision-
making. It entails the estimation of expected future trajecto-
ries of variables of interest under alternative courses of ac-
tion (or treatment strategies) given observed history. Treat-
ment strategies of interest are usually time varying (mean-
ing they comprise decisions at multiple time points) and dy-
namic (meaning the treatment decision at each time point
is a function of history up to that time point).
As an example, consider the problem of fluid administra-
tion in Intensive Care Units (ICUs) [1]. It is frequently
necessary for physicians to adopt strategies that admin-
ister large volumes of fluids to increase blood pressure
* Co-first authors. Correspondence to: Li-wei Lehman
(lilehman@mit.edu), Zach Shahn (zach.shahn@ibm.com).
Copyright c©2020 by the authors.
and promote blood perfusion through organs in septic pa-
tients. However, such strategies can lead to fluid overload,
which can have serious adverse downstream effects such as
pulmonary edema. Fluid administration strategies are time
varying and dynamic because at each time point physi-
cians decide the volume of fluid to administer based on
observed patient history (e.g. blood pressure and volume
of fluid already administered) up to that time point. To aid
in the choice between alternative dynamic fluid adminis-
tration strategies, it would be desirable to obtain counter-
factual predictions of a patient’s probability of developing
fluid overload (and other outcomes of interest) were they to
follow each alternative strategy going forward given their
observed covariate history up to the current time.
Counterfactual prediction is an inherently causal task in
that it must account for the causal effects of following dif-
ferent treatment strategies. When treatment strategies of in-
terest are time-varying, so-called “g-methods” [2, 3] are
required to estimate their effects. G-methods include g-
computation [4–6], structural nested models [7, 8], and
marginal structural models [9, 10]. Of these methods, g-
computation is best suited for estimating effects of general
dynamic treatment strategies conditional on high dimen-
sional patient histories [11].
G-computation works by estimating the conditional dis-
tribution of relevant covariates given covariate and treat-
ment history at each time point, then producing Monte
Carlo estimates of counterfactual outcomes by simulating
forward patient trajectories under treatment strategies of
interest. Regression model(s) for the covariates and out-
comes at each time point conditional on observed history
are a critical component of this method. While any regres-
sion models could in theory be input to the G-computation
algorithm, most existing G-computation implementations
have employed simple regression models with limited ca-
pacity to capture complex temporal and nonlinear depen-
dence structures. In recent years, sequential deep learning
methods such as Recurrent Neural Networks (RNNs) have
achieved state of the art performance in predictive model-
ing of complex time series data while imposing minimal
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modeling assumptions. In this paper, we propose G-Net, a
sequential deep learning framework for G-computation. G-
Net admits the use of recurrent networks such as LSTMs to
model covariates in a manner suitable for G-computation.
The G-Net framework is flexible and allows for various
configurations depending on the problem at hand. To the
best of our knowledge, this is the first work to investigate a
RNN based approach to G-computation.
Unfortunately, it is impossible to reliably evaluate coun-
terfactual predictions on real data, since only the outcomes
corresponding to treatment strategies that were actually fol-
lowed can be observed. Consequently, to explore and eval-
uate various implementations of G-Net, we used simulated
data in which counterfactual ground truth can be known.
We used CVSim [12], a well established mechanistic model
of the cardiovascular system, to estimate counterfactual
simulated patient trajectories under various fluid and vaso-
pressor administration strategies. These experiments pro-
vide a template for causal model evaluation using complex
and physiologically realistic simulated longitudinal data.
2 Related Work
Several recent works have proposed a deep learning frame-
work for counterfactual prediction from observational data,
including [13–15]. However, these works have mostly fo-
cused on learning point exposure as opposed to time-
varying treatment effects, which are the focus of this paper.
G-computation for estimating time-varying treatment ef-
fects was first proposed by Robins [4]. Illustrative appli-
cations of the general approach are provided in [6, 16],
and summaries of g-computation (and other “g-methods”
for estimating time-varying treatment effects) can be found
in [2, 3]. The g-computation algorithm takes arbitrary re-
gression models as inputs. While most applications (e.g. [6,
16]) have thus far employed classical generalized linear
models, there is no conceptual barrier to using more com-
plex machine learning regression models. RNNs, and in
particular LSTMs, have achieved state of the art perfor-
mance on a wide variety of time series regression tasks,
including healthcare related tasks [17–19]. However, de-
spite the popularity and success of RNNs for time series
regression, we have not seen in the literature any “deep”
implementation of g-computation.
Recently, Lim et al. [20] plugged RNN regression mod-
els into history adjusted marginal structural models
(MSM) [21] to make counterfactual predictions. However,
these MSMs can only make counterfactual predictions un-
der static time-varying treatment strategies that do not de-
pend on recent covariate history. For example, a history
adjusted MSM [20] could estimate the probability of fluid
overload given patient history under the (static) treatment
strategy “give 1 liter fluid each hour for the next 3 hours”,
but it could not estimate the probability of fluid overload
given patient history under the (dynamic) treatment strat-
egy “each hour for the next 3 hours, if blood pressure
is less than 65 then give 1 liter fluids, otherwise give 0
liters”. History adjusted MSMs cannot estimate effects of
time-varying treatment strategies that respond to changes
in the patient’s health history, but g-computation can. Fur-
ther, g-computation is able to straightforwardly estimate
the distribution of a counterfactual outcome under a time-
varying treatment strategy. This is not straightforward to do
with history adjusted MSMs.
Schulam and Saria [22] propose Counterfactual Gaus-
sian Processes, an implementation of continuous time g-
computation, and like us apply their method to ICU data.
They only consider static time-varying treatment strate-
gies, though it appears that their method might straightfor-
wardly be extended to handle dynamic strategies as well.
An advantage of Gaussian processes is interpretable un-
certainty quantification. However, GPs are intractable for
large datasets since they have time complexity of O(N3),
where N is the number of observations [23]. Sparse GPs,
which introduceM inducing points, have at leastO(M2N)
[23] time complexity. RNNs are more scalable. Recurrent
dropout can also be employed in RNN based implemen-
tations to produce uncertainty estimates that approximate
posterior distributions from a Gaussian process [24].
3 G-computation for counterfactual
prediction
Our goal is to predict patient outcomes under various future
treatment strategies given observed patient histories. Let:
• t ∈ {0, . . . ,K} denote time, assumed discrete, with
K being the end of followup;
• At denote the observed treatment action at time t;
• Yt denote the observed value of the outcome at time t
• Lt denote a vector of covariates at time t that may
influence treatment decisions or be associated with the
outcome;
• X¯t denote the history X0, . . . , Xt and Xt denote the
future Xt, . . . , XK for arbitrary time varying vari-
able X .
At each time point, we assume the causal ordering
(Lt, At, Yt). Let Ht ≡ (L¯t, A¯t−1) denote patient history
preceding treatment at time t. A dynamic treatment strat-
egy g is a collection of functions {g0, . . . , gK}, one per
time point, such that gt maps Ht onto a treatment action at
time t. A simple dynamic strategy for fluid volume might
be gt(Ht) = .5× 1{bpt < 65}, i.e. give .5 liters of fluid if
mean arterial blood pressure is less than 65 at time t.
Let Yt(g) denote the counterfactual outcome that would
be observed at time t had, possibly contrary to fact, treat-
ment strategy g been followed from baseline [4]. Further,
let Yt(A¯m−1, gm) with t ≥ m denote the counterfactual
outcome that would be observed had the patient received
their observed treatments A¯m−1 through time m − 1 then
followed strategy g from time m onward.
In counterfactual point prediction, our goal is to estimate
expected counterfactual patient outcome trajectories
{E[Yt(A¯m−1, gm)|Hm], t ≥ m} (1)
given observed patient history through time m for any m
and any specified treatment strategy g. We might also be
interested in estimating the counterfactual outcome distri-
butions at future time points
{p(Yt(A¯m−1, gm)|Hm), t ≥ m}. (2)
If we do not condition on anything in Hm, then (1) is an
expectation (and (2) a distribution) over the full population.
If we condition on a small subset of variables contained in
patient history, then (1) is an expectation (and (2) a distri-
bution) over a sub-population. If we condition on all ele-
ments of a patient history, then (1) is still technically only
an expectation (and (2) a distribution) over a hypothetical
sub-population with the exact patient history conditioned
on, but in this case (1) and (2) practically amount to what
is usually meant by personalized prediction.
Under the below standard assumptions, we can estimate (1)
and (2) through g-computation [4].
1. Consistency: Y¯K(A¯K) = Y¯K
2. Sequential Exchangeability: Y t ⊥ At|Ht ∀t
3. Positivity: P (At = gt(Ht)) > 0 ∀{Ht : P (Ht) > 0}
Assumption 1 states that the observed outcome is equal to
the counterfactual outcome corresponding to the observed
treatment. Assumption 2 states that there is no unobserved
confounding of treatment at any time and any future out-
come. Assumption 2 would hold, for example, under the
conditions depicted in Figure 1. Positivity states that the
counterfactual treatment strategy of interest has some non-
zero probability of actually being followed. Under the as-
sumption that we specify certain predictive models cor-
rectly such that their predictions extrapolate to parts of a
joint distribution that they were not trained on, positivity is
not strictly necessary.
Under assumptions 1-3, for t = m we have simply that
p(Ym(A¯m−1, gm)|Hm) = p(Ym|Hm, Am = gm(Hm)), (3)
i.e. the conditional distribution of the counterfactual is sim-
ply the conditional distribution of the observed outcome
given patient history and given that treatment follows the
strategy of interest. For t > m, things are slightly more
complex because we need to adjust for time-varying con-
founding. With Xi:j = Xi, . . . , Xj for any random vari-
able X, under Assumptions 1-3 the g-formula yields
Figure 1: A causal DAG representing a data generating process
in which Assumption 2 (sequential exchangeability) holds. This
DAG represents a simple two time step process where the out-
come is measured only after the final time step. However, its
salient property is that all variables influencing treatment (i.e.
with arrows directly into treatment) and associated with future
outcomes are measured.
p(Yt(A¯m−1, g
m
) = y|Hm)
=
∫
lm+1:t
p(Yt = y|Hm, Lm+1:t = lm+1:t, Am:t = g(Hm:t))
×
t∏
j=m+1
p(Lj = lj |Hm, Lm+1:j−1 = lm+1:j−1,
Am,j−1 = g(Hm, lm+1:j−1)). (4)
It is not generally possible to compute this integral in
closed form, but it could be approximated through Monte-
Carlo simulation. We repeat the recursive process shown in
Algorithm 1M times. (Here the outcome Yt is without loss
of generality deemed to be a variable in the vector Lt+1.)
At the end of this process, we have M simulated draws of
the counterfactual outcome for each time t = {m, . . . ,K}.
For each t, the empirical distribution of these draws con-
stitutes a Monte-Carlo approximation of the counterfac-
tual outcome distribution (2). The sample averages of the
draws at each time t are an estimate of the conditional
expectations (1) and can serve as point predictions for
Yt(A¯m−1, gm) in a patient with history Hm.
Key to the g-computation algorithm is the ability to simu-
late from joint conditional distributions p(Lt|L¯t−1, A¯t−1)
of the covariates given patient history at time t. Of course,
in practice we do not have prior knowledge of these condi-
tional distributions and need to estimate them from data.
Most implementations use generalized linear regression
models to estimate the conditional distributions of the co-
variates. Often, these models do not capture temporal de-
pendencies present in the patient data. We propose the G-
Net for this task.
4 G-Net Design
The proposed G-Net framework depicted in Figure 2 en-
ables the use of sequential deep learning models to esti-
mate conditional distributions p(L¯t|L¯t−1, A¯t−1) of covari-
ates given history at each time point and perform the G-
Figure 2: The G-Net: A flexible sequential deep learning framework for g-computation.
Algorithm 1: G-Computation (One simulation)
1 Set a∗m = gm(Hm)
2 Simulate and record y∗m from p(Ym|Hm, Am = a∗m)
3 Simulate l∗m+1 from p(Lm+1|Hm, Am = a∗m)
4 Set a∗m+1 = gm(Hm, l
∗
m+1, a
∗
m)
5 Simulate and record y∗m+1 from
p(Ym+1|Hm, Lm+1 = l∗m+1, Am = a∗m, Am+1 = a∗m+1)
6 Simulate l∗m+2 from p(Lm+2|Hm, Lm+1 = l∗m+1, Am =
a∗m, Am+1 = a
∗
m+1)
7 Continue simulations through time K
computation algorithm described in Algorithm 1 to sim-
ulate covariates under various treatment strategies. In this
setting, without loss of generality, we set Yt as one of the
co-variates in L for notational simplicity.
Let L0t , . . . , L
p−1
t denote p components of the
vector Lt, where each component L
j
t could be
multivariate. We impose an arbitrary ordering
L01, L
1
1, L
2
1, . . . , L
p−1
1 , A1, . . . , L
0
K , L
1
K , L
2
K , . . . , L
p−1
K , Ak
and estimate the conditional distributions of each Ljt given
all variables preceding it in this ordering. At simulation
time, we exploit the basic probability identity
p(Lt|L¯t−1, A¯t−1) = p(L0t |L¯t−1, A¯t−1)× p(L1t |L0t , L¯t−1, A¯t−1)
× · · · × p(Lp−1t |L0t , . . . , Lp−2t , L¯t−1, A¯t−1)
to simulate from p(Lt|L¯t−1, A¯t−1) by sequentially sim-
ulating each Ljt from p(L
j
t |L0t , . . . , Lj−1t , L¯t−1, A¯t−1).
There are at least two reasons to allow for subdivision of
the covariates. First, if covariates are of different types (e.g.
continuous, categorical, count, etc.), it is difficult to simul-
taneously simulate from their joint distribution. Second,
customizing models for each covariate component can po-
tentially lead to better performance. Figure 2 illustrates this
decomposition where at each time point the components
are depicted via ordered (grey shaded) boxes that are re-
sponsible for the estimation of the various terms needed to
compute the conditional distributions. One could set p = 1
and model all covariates simultaneously or at the other ex-
treme set p to be the total number of variables.
The sequential model used in G-Net provides
us with estimates of the conditional expectations
E[Ljt |L¯t−1, L0t , . . . , Lj−1t , A¯t−1] for all t and j. To
simulate from p(Ljt |L¯t−1, L0t , . . . , Lj−1t , A¯t−1), we pro-
ceed as follows. If Ljt is multinomial, its conditional
expectation defines its conditional density. If Ljt has a
continuous density, there are various approaches we might
take to simulate from its conditional distribution. Without
making parametric assumptions, we could simulate from
Ljt |L0t , . . . , Lj−1t , L¯t−1, A¯t−1 ∼
Eˆ[Ljt |L0t , . . . , Lj−1t , L¯t−1, A¯t−1] + jt (5)
where jt is a draw from the empirical distribution of the
residuals Ljt − Lˆjt in a holdout set not used to fit the
model parameters used to generate Lˆjt as an estimate of
E[Ljt |L0t , . . . , Lj−1t , L¯t−1, A¯t−1]. This method makes the
simplifying assumption that the covariate error distribution
does not depend on patient history. This is the approach
we take in the experiments in this paper, and is depicted
in the simulation noise nodes at the top of Figure 2. Al-
ternatively, we might specify a parametric distribution for
Ljt−E[Ljt |L0t , . . . , Lj−1t , L¯t−1, A¯t−1], e.g. a Gaussian, and
directly estimate its parameters by maximum likelihood.
To obtain the estimates for the conditional distribution of
covariates, G-Net admits sequential modeling of patients’
data using the group decomposition and arbitrary ordering
outlined before. As shown in the yellow boxes in Figure 2,
at each time t, a representationRt of the patient history can
be computed as
Rt = rt(L¯t, A¯t; Θ) (6)
where Θ represents model parameters learned during train-
ing. In its simplest form, rt may just be an identity func-
tion passing the covariates. In other configurations (e.g.
using the selector in Figure 2), rt can be used to provide
abstractions of histories using sequential learning architec-
tures such as RNN. This formulation of rt allows for a great
deal of flexibility in how information is shared across vari-
ables and time.
Estimates from each of the p covariate groups can then be
obtained, as shown in Figure 2, by successive estimation
of conditional expectations of covariates. Specifically, the
conditional expectation of each Ljt+1, 0 ≤ j < p given the
representation of patient history Rt and the other variables
from time t + 1 that precede it in the arbitrary predefined
ordering is estimated by the functions f jt . The complete
sequence can be given as follows:
L0t+1 = f
0
t (Rt; Λ0)
L1t+1 = f
1
t (Rt, L
0
t+1; Λ1)
· · ·
Ljt+1 = f
j
t (Rt, [L
1
t+1, . . . , L
j−1
t+1 ]; Λj)
· · · (7)
where, each of the f jt represents the specialized estimation
function for group j and Λj are the learnable parameters
for the same. Depending on modeling choices, f jt can
be sequential models specialized for group j or models
focusing only on the time step t (e.g. linear models).
Given G-Net parameters, the distribution of the Monte
Carlo simulations produced by G-computation Algorithm
1 constitute an estimate of uncertainty about a counter-
factual prediction. But this estimate ignores uncertainty
about the G-Net parameter estimates themselves. One way
to incorporate such model uncertainty would be to fit a
Bayesian model and, before each Monte Carlo trajectory
simulation in G-computation, draw new network parame-
ters from their posterior distribution. These Monte Carlo
draws would be from the posterior predictive distribution
of the counterfactual outcome. Bayesian deep learning
can be prohibitively computationally intensive, but can be
approximated through dropout [24]. First, we fit the RNN
component of the G-Net using recurrent dropout, with
dropout masks at each layer held constant across time as
described in [24]. Let M denote a dropout mask constant
across time for each layer of the RNN, Θˆ(M) denote
estimated RNN parameters with mask M applied, and pM
denote the distribution from which M was sampled during
training. Then, during g-computation, we add step 0 to the
beginning of Algorithm 1 before each simulation:
Step 0 (dropout) : Sample D∗ ∼ pD
and compute all simulations plugging
EˆΘ(D)[L
j
t |L1t , . . . , Lj−1t , L¯t−1, A¯t−1] into (5). Then
draws of Θˆ(D) are from an approximation to the posterior
distribution of Θ under a particular Gaussian Process prior.
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Figure 3: Covariates trajectories for the same patient (i.e. the
same random seed) under two different treatments go (blue) and
gc (red). After the treatment strategies diverge at middle of tra-
jectory, t = 34 (black dashed line), gc delivers a large fluid dose
while go does not, temporarily pushing AP and CVP higher under
the gc regime than the go regime.
Therefore, the Monte Carlo simulations obtained from
g-computation incorporating dropout (i.e. adding step 0 as
above) approximate draws from the posterior predictive
distribution of the counterfactual outcome.
The parameters, Θ and Λ, are learned by optimizing a loss
function forcing the G-Net to accurately estimate covari-
ates Lt at each time point t using standard gradient de-
scent techniques. It is to be noted that it is necessary to
use teacher-forcing (using observed values of Ljt+t as ar-
guments to ft in equation ) to obtain unbiased estimates of
ft, as shown in Figure 2.
5 Simulation Experiments Using CVSim
To evaluate counterfactual predictions, it is necessary to
use simulated data in which counterfactual ground truth for
outcomes under alternative treatment strategies is known.
To this end, we performed experiments on data generated
by CVSim [25], a program that simulates the dynamics of
the human cardiovascular system.
Data Generation: We generated an ‘observational’ dataset
Do under treatment regime go and two ‘counterfactual’
datasets Dc1 and Dc2 under treatment regimes gc1 and gc2.
The data generating processes producing Do and Dcj were
the same except for the treatment assignment rules. For
each j, gcj was identical to go for the first m − 1 simu-
lation time steps before diverging to a different treatment
rule for time steps m to K as illustrated in Figure 3.
A CVSim 6-compartment circulatory model takes as inputs
28 variables that together govern a hemodynamic system.
It then deterministically simulates forward in time a set of
25 output variables according to a collection of differential
equations (parameterized by the input variables) modeling
hemodynamics. Important variables in CVSim include ar-
terial pressure (AP), central venous pressure (CVP), total
blood volume (TBV), and total peripheral resistance (TPR).
In real patients, physicians observe AP and CVP and seek
to keep them above a clinically safe threshold. They do this
by intervening on TBV (through fluid administration) and
TPR (through vasopressors).
We defined simulated treatment interventions that were de-
signed to mimic the impact of fluids and vasopressors.
These simulated interventions alter the natural course of
the simulation by increasing either TBV (in the case of the
simulated fluids intervention) or TPR (in the case of the
simulated vasopressor intervention). We generated patients
by randomly initiating baseline inputs (which we hid from
our G-Nets to make this a stochastic modeling problem)
within plausible physiologic ranges, then using CVSim to
simulate covariates forward, intervening according to the
relevant treatment strategy at each timestep. Full details of
the simulation process can be found in the Appendix.
Under (stochastic) observational treatment strategy go, the
probability of receiving a non-zero vasopressor or fluid
dose at a given time increases as MAP and CVP decrease
according to a logistic regression function. Given that a
dose is non-zero, the exact amount is drawn from a normal
distribution with mean inversely proportional to MAP and
CVP. Since all drivers of treatment under go are observed in
our data, the sequential exchangeability assumption holds
and g-computation may be validly applied.
gc1 is similar to go, except it is a deterministic treatment
strategy and the functions linking treatment and dose to co-
variates have different coefficents. Under gc2, treatment is
always withheld. Again, details are in the Appendix.
Experiment Setup: We set ourselves the task of training a
G-Net on Do and using it to predict the trajectories of pa-
tients inDcj for time stepsm toK for each j. This setup is
designed to evaluate the performance of a G-Net in a situa-
tion in which we observe data from past patients (Do) who
received usual care (go) for K timesteps and would like to
predict how a new patient who has been observed for m
timesteps would fare were they to follow a different treat-
ment strategy of interest (gcj) for timestepsm toK. This is
a standard use case for counterfactual prediction. Dcj pro-
vides ground truth for a collection of patients whose tra-
jectories follow just the path we are interested in predict-
ing. Thus, by aggregating predictive performance metrics
across simulated patients in Dcj we generate measures of
the population level performance of our G-Net at the coun-
terfactual prediction task for which it was intended.
As shown in Table 1, we explore two specific criteria: (a)
using sequential vs. Identity functions for rt and (b) using
sequential models of entire patient history vs. linear models
Table 1: Experimental Model Setup Grid: Each cell summarizes
the instantiations: M1 (Linear), M2 (LSTM ), M3 (LSTM ),
and M4 (LSTM )), of G-Net used in our experiments.
With pass thru rt With sequential rt
M1 (Linear) M2 (LSTM )
fi:LR • rt: identity • rt: LSTM
• p = 2 • p = 2
• (f0, f1): linear layers. • (f0, f1): linear layers.
M3 (LSTM ) M4 (LSTM )
fi:RNN • rt: identity • rt: LSTM
• p = 2 • p = 2
• (f0, f1): LSTMs. • (f0, f1): LSTMs
Figure 4: 100 G-Net simulated trajectories (blue) and ground
truth (red) for one patient under gC1.
focusing only on current time point for ft. This provides us
4 different implementations of G-Net.
The best parameters for each model found from grid search
are as follows. For M2 (LSTM ) the hidden dimension
for the representational LSTM is 30, the hidden dimen-
sion for the categorical LSTM is 5, the hidden dimension
for the continuous LSTM is 30, and the learning rate is
.001. For M3 (LSTM ), the hidden dimension for the cat-
egorical LSTM is 10, the hidden dimension for the con-
tinuous LSTM is 75, and the learning rate is .005. For
M4 (LSTM ), the hidden dimension for the representa-
tion LSTM is 30, the hidden dimension for the categorical
LSTM is 5, the hidden dimension for the continuous LSTM
is 30, and the learning rate is .001. For all models, the batch
size used was 64. These parameters were the ones used to
achieve the results presented in the experiments and results
section.
Evaluation: We evaluate the accuracy (Mean Squared Er-
ror - MSE) and calibration of the counterfactual simula-
tions generated by our G-Nets as follows. Say Dcj com-
prisesNc trajectories of random variable (L¯
cj
K , A¯
cj
K). Given
observed history Hcjmi = (L¯
cj
mi, A¯
cj
m−1i) for patient i from
(a) MSE gc1 (b) MSE gc2
(c) Calibration gc1 (d) Calibration gc2
Figure 5: Performance of various models: MSE and calibration over time for gc1 and gc2
Dcj , a G-Net G fit to Do produces M (in our experiments,
100) simulations of the counterfactual covariate trajectory
{L˜cjti (Hcjmi, G, k) : t ∈ m : K; k ∈ 1 : M}. These simu-
lated trajectories are the light blue lines in Figure 4.
The G-Net’s point prediction of Lti is its estimate of
E[Lt(gcj)|Hm = Hmi], i.e. the average of the M simula-
tions Lˆti(G) ≡ 1M
∑M
k=1 L˜
c
t(H
c
mi, G, k). This is the dark
blue line in Figure 4.
If Lt has dimension d, we compute the MSE of coun-
terfactual predictions by a G-Net G in the dataset Dc as
1
Nc(K−m)d
∑Nc
i=1
∑K
t=m
∑d
h=1(L
h,CF
ti − Lˆh,CFti (G))2.
We assess the calibration of a G-Net G as follows. Given
lower and upper quantiles αlow and αhigh, the calibration
measures the frequency with which the actual counterfac-
tual covariate Lh,cjti is between the αlow and αhigh quan-
tiles of the M simulations {L˜h,cjti (Hcjmi, G, k) : k ∈ 1 :
M}. If this frequency is approximately αhigh − αlow, then
G is well calibrated.
Experiments/Results: Using CVSim, we generated a to-
tal of 10,000 trajectories in Do (No = 10, 000), of which
80% were used for training, and the remaining 20% for val-
idation. For testing, we generated 500 observations in the
Dcj datasets (Nc = 500). We included a total of 18 output
variables (including all variables influencing treatment as-
signment under go) from CVSim to construct Do and Dcj ;
each trajectory is of length 64 time steps (d=18, K=64). In
each Dcj , the switching time point m from go to gc is fixed
at 34 for all trajectories (m = 34).
We fit the four models described in Table 1 to the training
portion of Do (80%), and used the remaining portion as
validation to tune our model hyperparameters. Next, given
observed covariate history through 34 time steps and treat-
ment history through 33 time steps of each trajectory in
each Dcj , we computed the MSE and calibration of the G-
Nets’ counterfactual predictions for time steps 34 to 64.
Figure 5 (a) and (b) illustrates the performance of the vari-
ous G-Net architectures in terms of MSE over time. Over-
all, for this experiment we found M3 (Identity function for
rt and LSTM for the fi functions), performed best over
both treatment strategies. Also, a comparative analysis of
M1 vs M3 (both with Identity representation function for
rt) and M2 vs M4 (both with LSTM representation func-
tions for rt) showed that G-Net provide better estimates of
conditional distributions by admitting sequential prediction
models focusing on the entire patient history compared to
prediction models focusing on a single time point.
Figure 5 (c) and (d) depicts calibration for the candidate
models. All of the calibration coverage rates are below the
nominal levels (they should be .5), though the RNN based
Figure 6: Estimated (G-Net M3 in Table 1) and actual population average trajectories under gc1 for select variables.
Figure 7: Treatment Effect for Selected Variables
G-Nets again perform better than the linear model imple-
mentation. This is in part because the counterfactual pre-
dictive density estimates in these experiments do not take
into account uncertainty about model parameter estimates,
which could be addressed with dropout as discussed in Sec-
tion 4.
The G-Net can also be used to estimate population aver-
age counterfactual outcomes and treatment effects, quanti-
ties sometimes more relevant to policy decisions than in-
dividual level counterfactual predictions. Figure 6 displays
G-Net (M3 from Table 1) estimates and true values of pop-
ulation average trajectories for select variables under gc1.
Figure 7 shows estimates and true values of the population
average treatment effect of following gc1 as opposed to gc2
on select variables. We see that the G-Net does a good job
of estimating these population level quantities of interest.
6 Discussion and Future Work
In the G-Net we have introduced a novel and flexible frame-
work for counterfactual prediction under dynamic treat-
ment strategies through G-computation using sequential
deep learning models. We have illustrated several imple-
mentations of the G-Net in a realistically complex simu-
lation setting where we had access to ground truth coun-
terfactual outcomes. In particular, we considered alterna-
tive approaches to representation learning that either share
representations of patient history across predictive tasks or
keep them separate. In the particular implementation we
considered, shared representations seemed to aid simple
linear classifiers but harm LSTMs.
The G-Net framework’s flexibility means that there are
many other alternative implementations to explore. For ex-
ample, we might consider alternative architectures for rep-
resenting patient history, such as attention mechanisms or
memory networks.
Another direction of future work is incorporation of prior
causal knowledge. For example, if it is known which vari-
ables are confounders and which merely predictive of the
outcome, we might include weights in the loss function
emphasizing faithful representation and prediction of con-
founding variables compared to non-confounders.
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A Appendix
A.1 CVSim
CVSim is a open-source cardiovascular simulator, aiming
for education and research purpose developed by Thomas
et al[12]. In this work, we focus on CVSim-6C which con-
sists of 6 components, functioning as pulmonary and sys-
temic veins, arteries, and micro-circulations respectively.
CVSim-6C is regulated by arterial baroreflex system to
simulate Sahs lumped hemodynamic model[12]. The ag-
gregate model is capable of simulating pulsatile wave-
forms, cardiac output and venous return curves, and sponta-
neous beat-to-beat hemodynamic variability. In this work,
we modified and built on CVSim by adding stochastic-
components to it for the purposes of evaluating our coun-
terfactual simulators. We call our stochastic simulation en-
gine S-CVSim.
A.2 Inputs of S-CVSim
By varying hemodynamic parameters of CVSim, it can
simulate cardiovascular system under various conditions.
We, therefore, sample values of a subset of model parame-
ters while initiating simulation at time 0 to obtain ideal dis-
tribution of trajectories. These model parameters are listed
at Table 2. Note that this does not necessarily mean val-
ues of input covariates would not exceed or drop below
such range at any time t, where t > 0..
Table 2: Names and corresponding ranges of input param-
eters of S-CVSim.
INPUT COVARIATES RANGE
Total Blood Volume 1,500 - 6,000
Nominal Heart Rate 40 - 160
Total Peripheral Resistance 0.1 - 1.4
Arterial Compliance 0.4 - 1.1
Pulmonary Arterial Compliance 0.1 - 19.9
Total Zero-pressure filling Volume 500 - 3,500
Pulmonary Arterial Compliance 2.0 - 3.4
Pulmonary Microcirculation Resistance 0.4 - 1.00
A.3 Outputs of S-CVSim
At each time t, CVSim-6C generates hemodynamic data
including vascular resistance and varieties of type of flow,
pressure, and volume. In addition to original 25 hemody-
namic outputs, we introduce 3 new outputs, including sys-
tolic blood pressure, diastolic blood pressure, and mean
arterial pressure, bringing the total number of output vari-
ables to 28. For this work, we only predict a subset of out-
put covariates highlighted in Table 3. A complete list of
output are listed in Table 3.
• Systoblic Blood Pressure (SBP) is defined as the
highest measured arterial blood pressure while heart
contracting.
• Diastolic Blood Pressure (DBP) is defined as the
lowest measured arterial blood pressure while heart
contracting.
• Mean Arterial Pressure (MAP) is defined as the av-
erage pressure in a patients arteries during one cardiac
cycle as follow formula. MAP = 2∗DBP+1∗SBP3
Table 3: Outputs of S-CVSim, Lt denotes all the output
of S-CVSim at time t; whereas, Lanyt denotes a subset of
output e.g. Lmapt represents mean arterial pressure at time
t. Covariates highlighted with * are the selected output.
OUTPUT COVARIATES
Left Ventricle Pressure* LVP
Left Ventricle Flow* LVQ
Left Ventricle Volume LVV
Left Ventricle Contractility* LVC
Right Ventricle Pressure* RVP
Right Ventricle Flow* RVQ
Right Ventricle Volume RVV
Right Ventricle Contractility* RVC
Central Venous Pressure* CVP
Central Venous Flow CVQ
Central Venous Volume CVV
Arterial Pressure* AP
Arterial Flow* AQ
Arterial Volume* AV
Pulmonary Arterial Pressure PAP
Pulmonary Arterial Flow PAQ
Pulmonary Arterial Volume PAV
Pulmonary Venous Pressure PVP
Pulmonary Venous Flow PVQ
Pulmonary Venous Volume* PVV
Heart Rate* HR
Arteriolar Resistance* AR
Venous Tone* VT
Total Blood Volume* TBV
Intra-thoracic Pressure* PTH
Mean Arterial Pressure* MAP
Systolic Blood Pressure* SBP
Diastolic Blood Pressure DBP
A.4 Simulation Process
To obtain observational data for our intended purpose, we
implemented and built two extra events, Disease, St and
Treatment, At. Note that at each time T , both St and At
could happen simultaneously but St also happens before
At. With these stochastic events,At and St,Dobs andDCF
can be simulated and obtained on S-CVSim.
A.4.1 Data Generation, Do, Dc
To simulate a patient trajectory under treatment strategy g,
we obtainDo andDc with the following algorithm for each
individual trajectory. Do, training set, consists of 10k tra-
jectories based on go.Dc, test set, consists of 1k trajectories
based on gc.
• Initialize input variables V1, ..., VN by drawing from
independent uniform distributions using a predefined
plausible physiological ranges for each variable as Ta-
ble 2 suggested.
• For t in 0:K
– Generate L∗t as Fsim,t(V, L¯∗t−1, At−1), where
A−1 is taken to be 0.
– If g = gc and t ≥ K2 :∗ Generate At as gc(L¯t)
– Else
∗ Generate At as go(L¯t)
A.4.2 Disease Simulation, St
We introduce the concept St to simulate hemodynamic in-
stability of cardiovascular system such as sepsis and bleed-
ing at each timestep. St consists of two events, sepsis and
blood loss. In module of St, we denote that P (St|Lt) =
0.05, and P (Sepsis|St) = P (BloodLoss|St) = 0.5; Note
that blood loss and sepsis events are mutually exclusive in
the simulation process at any time t.
• When sepsis happens, Ltprt+1 = αtpr ∗ Ltprt where 0 <
αtpr ≤ 0.7, meaning Ltprt , total peripheral resistance,
would decrease in αtpr at next time t+ 1
• When blood loss happens, Ltbvt+1 = αtbv ∗
Ltbvt where 0 < αtbv ≤ 0.95, meaning that Ltbvt , to-
tal blood volume would decrease in αtbv at next time
t+ 1.
A.4.3 Treatment Simulation, At
We developed two treatment strategy go, policy for obser-
vational regime and gc, policy for counterfactual policy, to
simulate clinical treatment and validate our model. Under
any given g, Aanyt is defined as g(Lt). Similar to disease
simulation, Aanyt is either A
1
t , increasing quantity of to-
tal blood volume or A2t increasing quantity of arterial
resistance. The probability of choosing fluids is equal to
vasopressor but will not be administered at the same time.
The dosage ofAt depends on a subset ofLt which indicates
hemodynamic balance. More specific, since adequate blood
pressure is an important clinical goal[26], we denote mean
arterial pressure, MAP, of 65 mmHg and central venous
pressure, CVP, of 10 mmHg as target goals. Therefore, We
define ∆map,t ≡ 65 − Lmapt and ∆cvp,t ≡ 10 − Lcvpt as
proxies of how much dosage should be delivered. The fol-
lowing section will discuss the difference of At between
gCF and gobs.
A.4.4 Observational Regime, go
Under gobs, probability and dosage of treatment are de-
noted as the followings
• Probability of treatment, P (At|Lt) = 11+e−x ,where
x = C1 ∗∆map + C2 ∗∆cvp + C0.
• If we administer fluids, we generate the dose (in
mL) A1t ∼ max(0, β11 ∗ ∆map,t + β12 ∗ ∆cvp,t +
N (1500, 1000)).
• If we administer vasopressors, we generate the dose
A2t ∼ max(0, β21 ∗∆map + β22 ∗∆cvp +N (0, 1)) if
U ∼ Uniform.
A.4.5 Counterfactual Regime, gc
Under gCF , probability and dosage of treatment are de-
noted as the followings
• Probability of treatment, P (At|Lt) = 1 if and only if
Lsbpt ≤ 100 and ShockIndex [26], L
hr
t
Lsbpt
,≤ 0.8.
• If we administer fluids, we generate the dose (in mL)
A1t ∼ max(0, β11 ∗∆map,t + β12 ∗∆cvp,t).
• If we administer vasopressors, we generate the dose
A2t ∼ max(0, β21 ∗ ∆map + β22 ∗ ∆cvp) if U ∼
Uniform.
We experimented with multiple parameters and opted to
use C0 = 0.02, C1 = 0.06, C2 = 0.24, β11 = 10, β
1
2 =
60, β21 = 0.1, β
2
2 = 0.15.
Figure 8: Causal DAG for Do generated under observa-
tional regime go. Green arrows denote directed paths from
treatments to outcomes. Treatment only depends on current
covariates. All covariates with arrows into treatment (i.e.
MAP, CVP, and ∆P ) are observed, satisfying the sequen-
tial exchangeability assumption as in Figure 1.
The DAG in Figure 8 depicts the causal structure of Do.
Note that only observed covariates have arrows pointing
into treatment (treatment is actually only a function of CVP,
MAP, and ∆P ), so that there is no unobserved confounding
and g-computation may be applied.
